Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIOPPO: Preoperative Chemotherapy and Carbon Ion Therapy in Pancreatic Cancer
NCT03822936Phase 2Terminated
- Sponsor
- Fondazione Centro Nazionale di Adroterapia Oncologica
- Start
- Feb 2018
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in pancreatic adenocarcinoma (PDAC), sponsored by Fondazione Centro Nazionale di Adroterapia Oncologica. Primary endpoint: Progression Free Survival at 1 year. Started Feb 2018; status: terminated.
02
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03822936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822936.